(Total Views: 614)
Posted On: 07/21/2020 11:39:31 AM
Post# of 154115
Some here (like Shopcop who bravely has me on "ignore"
say "Take this as a gift to add more!" when in reality, what it actually is, is another shining example of an inexperienced CEO who should have managed the expectations of his shareholders better, by being clear that it was possible that safety data could come in on Monday, but efficacy data would likely take longer. Telling us about the safety profile of leronlimab is like telling us the sun will rise in the east tomorrow. WE KNOW! HIV patients taking leronlimab for 5 years with no SAE's have pretty much put any fears to rest in that department.
I'm NOT bashing NP, just calling things as they actually are. He was basically telegraphing "great efficacy data coming momentarily!" which is why we were all so excited for 3am Tuesday morning. NP is (and this is a bit of a joke) the poster boy for "every silver lining has a cloud."
say "Take this as a gift to add more!" when in reality, what it actually is, is another shining example of an inexperienced CEO who should have managed the expectations of his shareholders better, by being clear that it was possible that safety data could come in on Monday, but efficacy data would likely take longer. Telling us about the safety profile of leronlimab is like telling us the sun will rise in the east tomorrow. WE KNOW! HIV patients taking leronlimab for 5 years with no SAE's have pretty much put any fears to rest in that department. I'm NOT bashing NP, just calling things as they actually are. He was basically telegraphing "great efficacy data coming momentarily!" which is why we were all so excited for 3am Tuesday morning. NP is (and this is a bit of a joke) the poster boy for "every silver lining has a cloud."
(6)
(2)
